LC-MS-based metabolite profiling of aqueous extract of Pergularia tomentosa L. and its anti-hyperglycemic effect

Document Type : Original Article


1 Department of Biology, Faculty of Science, University of Jiroft, Jiroft, Iran

2 Dipartimento di Farmacia, Università degli Studi di Salerno, Via Giovanni Paolo II 132, 84084 Fisciano, Salerno, Italy

3 Department of Pharmacognosy, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran


Objective(s): In this study, to find scientific evidence for the traditional use of Pergularia tomentosa as an anti-diabetic remedy, the effects of its aqueous extract on streptozotocin-induced diabetes mellitus in rats were evaluated.
Materials and Methods: Wistar rats were fasted overnight and diabetes mellitus was induced using streptozotocin (50 mg/kg body weight). The rats were randomly and equally divided into four groups (n=5): group I (normoglycaemic control), group II (diabetic rats), group III (diabetic rats treated with 200 mg/kg BW of an aqueous extract of P. tomentosa), group IV (normoglycemic rats treated with 200 mg/kg BW of an aqueous extract of P. tomentosa). Chemical profiling of the aqueous extract was carried out using liquid chromatography coupled with electrospray ionization and multiple-stage linear ion-trap and orbitrap high-resolution mass spectrometry (LC-ESI/LTQOrbitrap/MS/MS). In addition, the quantitative determination of the main cardenolides in the extract was carried out by an analytical approach based on LC coupled to tandem mass spectrometry with ESI source and hybrid triple quadrupole-linear ion trap mass analyzer (LC-ESI/QTrap/MS/MS).
Results: Aqueous extract of P. tomentosa showed a reasonable reduction in blood glucose level. Probably, the P. tomentosa effect on hyperglycemic and hyperlipidemic diabetic animals was associated with antioxidant properties, triglyceride levels, as well as liver enzymes. Meanwhile, LC-ESI/LTQOrbitrap/MS/MS analysis led to identification of double-linked cardenolides along with cardenolides and flavone glycosides as the main bioactive compounds.
Conclusion: The extract decreased the glucose level and induced a beneficial effect on the lipid profile, probably due to the presence of cardenolide glycosides.


1. Askari G, Rouhani MH, Ghaedi E, Ghavami A, Nouri M, Mohammadi H. Effect of Nigella sativa (black seed) supplementation on glycemic control: A systematic review and meta‐analysis of clinical trials. Phyther Res 2019;33:1341-1352. 
2. Verspohl EJ, Bauer K, Neddermann E. Antidiabetic effect of Cinnamomum cassia and Cinnamomum zeylanicum in vivo and in vitro. Phyther Res An Int J Devoted to Pharmacol Toxicol Eval Nat Prod Deriv 2005; 19: 203–206. 
3. Hajihasani MM, Soheili V, Zirak MR, Sahebkar A, Shakeri A. Natural products as safeguards against monosodium glutamate-induced toxicity. Iran J Basic Med Sci 2020; 23: 416-430.
4. Radmehr V, Ahangarpour A, Mard SA, Khorsandi L. Crocin ameliorates MicroRNAs-associated ER stress in type 2 diabetes induced by methylglyoxal. Iran J Basic Med Sci 2022; 25: 179-186.
5. Semwal DK, Kumar A, Aswal S, Chauhan A, Semwal RB. Protective and therapeutic effects of natural products against diabetes mellitus via regenerating pancreatic β-cells and restoring their dysfunction. Phyther Res 2021; 35: 1218–1229. 
6. Dehghan H, Sarrafi Y, Salehi P. Antioxidant and antidiabetic activities of 11 herbal plants from Hyrcania region, Iran. J Food Drug Anal 2016; 24: 179–188. 
7. Gajdosik A, Gajdosikova A, Stefek M, Navarova J, Hozova R. Streptozotocin-induced experimental diabetes in male Wistar rats. Gen Physiol Biophys 1999; 18: 54–62. 
8. Ghadi FE, Malhotra A, Ghara AR, Dhawan DK. Chemopreventive effects of selenium on cancer marker indices and ultrastructural changes during 1, 2 dimethylhydrazine-induced colon carcinogenesis in rats. J Gastrointest Cancer 2013; 44: 54–59. 
9. Ramzani Ghara A, Ezzati Ghadi F, Hosseini SH, Piacente S, Cerulli A, Alizadeh A, et al. Antioxidant and antidiabetic effect of capparis decidua edgew (Forssk.) extract on liver and pancreas of streptozotocin-induced diabetic rats. J Appl Biotechnol Reports 2021; 8: 76-82. 
10. Volpe CMO, Villar-Delfino PH, Dos Anjos PMF, Nogueira-Machado JA. Cellular death, reactive oxygen species (ROS) and diabetic complications. Cell Death Dis 2018; 9: 1–9. 
11. Wang W, Lee P, Yeh H, Smirnova I V, Choi I. Effects of acute and chronic hyperglycemia on the neurochemical profiles in the rat brain with streptozotocin‐induced diabetes detected using in vivo1H MR spectroscopy at 9.4 T. J Neurochem 2012; 121: 407–417. 
12. Al-Said MS, Hifnawy MS, McPhail AT, McPhail DR. Ghalakinoside, a cytotoxic cardiac glycoside from Pergularia tomentosa. Phytochemistry 1988; 27: 3245–3250. 
13. Liu Z, Zhai J, Han N, Yin J. Assessment of anti-diabetic activity of the aqueous extract of leaves of Astilboides tabularis. J Ethnopharmacol 2016; 194: 635–641. 
14. Kooshki A, Tofighiyan T, Rastgoo N, Rakhshani MH, Miri M. Effect of Nigella sativa oil supplement on risk factors for cardiovascular diseases in patients with type 2 diabetes mellitus. Phyther Res 2020; 34: 2706–2711. 
15. Sarkodie JA, Squire SA, Bekoe EO, Domozoro CYF, Kretchy IA, Ahiagbe MKJ, et al. Antioxidant and antimicrobial capacities of ethanolic extract of Pergularia daemia leaves: a possible substitute in diabetic management. J Complement Integr Med 2016; 13: 239-245. 
16. Gohar AA, El-Olemy MM, Abdel-Sattar E, El-Said M, Niwa M. Cardenolides and β-Sitosterol Glucoside from Pergularia tomentosa L. Nat Prod Sci 2000; 6: 142–146. 
17. Piacente S, Masullo M, De Nève N, Dewelle J, Hamed A, Kiss R, et al. Cardenolides from Pergularia tomentosa display cytotoxic activity resulting from their potent inhibition of Na+/K+-ATPase. J Nat Prod 2009; 72: 1087–1091. 
18. Hamed AI, Plaza A, Balestrieri ML, Mahalel UA, Springuel I V, Oleszek W, et al. Cardenolide glycosides from Pergularia tomentosa and their proapoptotic activity in Kaposi’s sarcoma cells. J Nat Prod 2006; 69: 1319–1322. 
19. Hosseini M, Ayyari M, Meyfour A, Piacente S, Cerulli A, Crawford A, et al. Cardenolide-rich fraction of Pergularia tomentosa as a novel antiangiogenic agent mainly targeting endothelial cell migration. DARU J Pharm Sci 2020; 28: 533–543. 
20. Hosseini SH, Masullo M, Cerulli A, Martucciello S, Ayyari M, Pizza C, et al. Antiproliferative cardenolides from the aerial parts of pergularia tomentosa. J Nat Prod 2019; 82: 74–79. 
21. Shahana MM, Mirhom YW, Generah AA, Aboutabi EA, Amer HA. Study into wild Egyptian plants potential medicinal activity. Ninth communication: hypoglycemic activity of some selected plants in normal fasting and alloxanised rats. Arch Exp Vet Med 1990; 44: 389–394. 
22. Martucciello S, Paolella G, Romanelli AM, Sposito S, Meola L, Cerulli A, et al. Pro-apoptotic and pro-autophagic properties of cardenolides from aerial parts of Pergularia tomentosa. Molecules 2022; 27: 4874. 
23. Hammiche V, Maiza K. Traditional medicine in Central Sahara: pharmacopoeia of Tassili N’ajjer. J Ethnopharmacol 2006; 105: 358-367. 
24. Napolitano A, Cerulli A, Pizza C, Piacente S. Multi-class polar lipid profiling in fresh and roasted hazelnut (Corylus avellana cultivar “Tonda di Giffoni”) by LC-ESI/LTQOrbitrap/MS/MSn. Food Chem 2018; 269: 125–135. 
25. Masullo M, Cerulli A, Montoro P, Pizza C, Piacente S. In depth LC-ESIMSn-guided phytochemical analysis of Ziziphus jujuba Mill. leaves. Phytochemistry 2019; 159: 148–158. 
26. OECD EPR. Organisation for Economic Co-operation and Development, Paris, 2001. URL http//www oecd-ilibrary org/content/book/9789264189867-en. 
27. Cerulli A, Napolitano A, Masullo M, Hošek J, Pizza C, Piacente S. Chestnut shells (Italian cultivar “Marrone di Roccadaspide” PGI): Antioxidant activity and chemical investigation with in depth LC-HRMS/MSn rationalization of tannins. Food Res Int 2020; 129: 108787. 
28. Goodies ME, Oghenesuvwe EE, Ejiroghene A. Effects of inhaled anaesthetic agents (Chloroform and Diethyl ether) on fasting blood glucose and haematological parameters in Wistar rats. Sky J Biochem Res 2015; 4: 13–15. 
29. Peng J, Luo F, Ruan G, Peng R, Li X. Hypertriglyceridemia and atherosclerosis. Lipids Health Dis 2017; 16: 1–12. 
30. Hamzeh S, Farokhi F, Heydari R, Manaffar R. Renoprotective effect of hydroalcoholic extract of Rheum ribes root in diabetic female rats. Avicenna J phytomedicine 2014; 4: 392. 
31. Carvalho E, Franceschi P, Feller A, Palmieri L, Wehrens R, Martens S. A targeted metabolomics approach to understand differences in flavonoid biosynthesis in red and yellow raspberries. Plant Physiol Biochem 2013; 72: 79–86. 
32. Andallu B, Kumar AVV, Varadacharyulu NC. Lipid abnormalities in streptozotocin-diabetes: Amelioration by Morus indica L. cv Suguna leaves. Int J Diabetes Dev Ctries 2009; 29: 123. 
33. Bakour M, El Menyiy N, El Ghouizi A, Lyoussi B. Hypoglycemic, hypolipidemic and hepato-protective effect of bee bread in streptozotocin-induced diabetic rats. Avicenna J Phytomedicine 2021; 11: 343. 
34. Furman BL. Streptozotocin‐induced diabetic models in mice and rats. Curr Protoc 2021; 1: e78. 
35. Ojiako OA, Chikezie PC, Ogbuji AC. Blood glucose level and lipid profile of alloxan-induced hyperglycemic rats treated with single and combinatorial herbal formulations. J Tradit Complement Med 2016; 6: 184–192. 
36. Tan Y, Cheong MS, Cheang WS. Roles of reactive oxygen species in vascular complications of diabetes: Therapeutic properties of medicinal plants and food. Oxygen 2022; 2: 246-268. 
37. Adaramoye O, Amanlou M, Habibi-Rezaei M, Pasalar P, Ali M-M. Methanolic extract of African mistletoe (Viscum album) improves carbohydrate metabolism and hyperlipidemia in streptozotocin-induced diabetic rats. Asian Pac J Trop Med 2012; 5: 427–433. 
38. Feitosa ACR, Feitosa-Filho GS, Freitas FR, Wajchenberg BL, Maranhão RC. Lipoprotein metabolism in patients with type 1 diabetes under intensive insulin treatment. Lipids Health Dis 2013; 12: 1–8. 
39. Chandramohan G, Al‐Numair KS, Sridevi M, Pugalendi KV. Antihyperlipidemic activity of 3‐hydroxymethyl xylitol, a novel antidiabetic compound isolated from Casearia esculenta (Roxb.) root, in streptozotocin‐diabetic rats. J Biochem Mol Toxicol 2010; 24: 95–101. 
40. Eleazu CO, Eleazu KC, Chukwuma S, Essien UN. Review of the mechanism of cell death resulting from streptozotocin challenge in experimental animals, its practical use and potential risk to humans. J diabetes Metab Disord 2013; 12: 1–7. 
41. Triner L, Killian P, Nahas GG. Ouabain hypoglycemia: insulin mediation. Science 1968; 162: 560-561. 
42. Kajikawa M, Fujimoto S, Tsuura Y, Mukai E, Takeda T, Hamamoto Y, et al. Ouabain suppresses glucose-induced mitochondrial ATP production and insulin release by generating reactive oxygen species in pancreatic islets. Diabetes 2002; 51: 2522–2529.